Public Release: 

CRF hosts meeting on advances for chronic total occlusions and left main interventions

Complex PCI: Left Main and CTO Summit will be held Feb. 23-25, 2012, in New York City

Cardiovascular Research Foundation

WHAT: The Complex PCI: Left Main and CTO Summit is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions. Topics at this year's summit will include:

  • When and why to open a CTO
  • Left main PCI vs. CABG: Patient selection
  • CTO angioplasty: Antegrade vs. retrograde approaches; wire and device selection, and essential techniques and tips
  • Basic and advanced imaging and physiologic lesion assessment to improve procedural results and late outcomes
  • Pharmacology essentials
  • Minimizing and managing complications

WHY: Leading practitioners of percutaneous coronary intervention must become experts at recanalizing chronic total occlusions, and with advanced techniques, success rates greater than 90% may be obtained. In addition, stenting of the unprotected left main coronary artery has emerged as a viable alternative to surgery in selected patients but requires a special skill set and understanding of anatomy, imaging, hemodynamic support, and adjunctive devices.

This year's conference will emphasize both advanced techniques and evidence-based medicine, featuring live case transmissions led by the world's leading experts in left main and CTO stenting.

WHEN: February 23 - 25, 2012

WHERE: New York Marriott Marquis Hotel
1535 Broadway
New York, NY


For more information visit:

HOW TO REGISTER: Media may apply for registration by visiting:

About CRF

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies, drugs, and therapies in the subspecialty of interventional cardiology and endovascular medicine. For more information visit:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.